Developer of vaccines for the treatment of cancer. The company is developing Anti-tumor Immune Redirection (AIR) a therapy that redirects the pre-existing immune memory from childhood vaccines or infections to fight cancer. They have developed a papillomavirus nanoparticle conjugated with viral antigens to treat cancer.
← All startups
VerImmune
SeedDeveloper of vaccines for the treatment of cancer. The company is developing Anti-tumor Immune Redirection (AIR) a therapy that redirects the pre-existing immune memory from childhood vaccines or infections to fight cancer. They have developed a papillomavirus nanoparticle conjugated with viral antigens to treat cancer.
About
Institutional investors
America’s Seed FundBeiley BiofundProxima VenturesMana VenturesGaingelsSeedFolioUlu VenturesNuFundMilitary Health
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.